PHSI periodically conducts surveys of practicing pharmacists to gain understanding of industry trends or current events impacting retail pharmacy. We invite you to share your insight and receive future internet and telephone surveys.
Do you feel like your organization understands the FDA’s Draft Guidance for Industry on Drug Importation?
We have reviewed the guidance and are taking a watch and wait approach: 75%
We have reviewed the guidance and are taking proactive steps to act on it: 25%
We have reviewed the guidance but do not feel like it will impact our organization: 0%
Not familiar/We have not reviewed the guidance: 0%
How will payers manage reimbursement of multiple interchangeable biosimilars?
MAC reimbursement: 10%
Generic non-MAC reimbursement rate: 10%
Brand reimbursement rate: 40%
Specialty drug specific rate: 40%
Average Sales Price (ASP): 0%
Average Manufacturer Price (AMP): 0%
National Average Drug Acquisition Cost (NADAC): 0%
In which area could you or your company most benefit from additional training?
Biosimilars and interchangeability requirements: 46.1%
Dynamics that drive PBM and health plan decisions: 15.4%
Various hurdles a prescription must clear before being dispensed: 15.4%
Changing 340B landscape: 15.4%
Flow of funds and prescriptions through the pharmacy channels: 7.7%
Pharmacy chain initiatives and strategy updates: 0%
968 Perry Highway
Pittsburgh, PA 15237
Get Directions »
Phone: (412) 635-4650
Follow/Subscribe: